Virtu Financial’s PDS Biotechnology PDSB Stock Holding History

Virtu Financial’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32,099	Closed	-$25K	–	2140
2025 Q4	$25K	Buy	+32,099	New	+$29K	﹤0.01%	1393
2025 Q3	–	Sell	-32,002	Closed	-$43K	–	1930
2025 Q2	$43K	Buy	+32,002	New	+$43.5K	﹤0.01%	1163
2025 Q1	–	Sell	-54,693	Closed	-$89K	–	1873
2024 Q4	$89K	Buy	+54,693	New	+$145K	﹤0.01%	1048
2024 Q1	–	Sell	-24,899	Closed	-$124K	–	1922
2023 Q4	$124K	Buy	+24,899	New	+$124K	0.01%	978
2022 Q3	–	Sell	-47,326	Closed	-$173K	–	2111
2022 Q2	$173K	Buy	+47,326	New	+$225K	0.01%	802
2021 Q4	–	Sell	-17,696	Closed	-$264K	–	2064
2021 Q3	$264K	Buy	+17,696	New	+$221K	0.02%	781
2021 Q2	–	Sell	-10,602	Closed	-$48K	–	1936
2021 Q1	$48K	Buy	+10,602	New	+$42.7K	﹤0.01%	1442
2020 Q4	–	Sell	-10,086	Closed	-$24K	–	1708
2020 Q3	$24K	Buy	+10,086	New	+$28.3K	﹤0.01%	907
2018 Q3	–	Sell	-1,557	Closed	-$32K	–	2016
2018 Q2	$32K	Buy	+1,557	New	+$32.5K	﹤0.01%	1821
2017 Q4	–	Sell	-827	Closed	-$177K	–	2827
2017 Q3	$177K	Buy	+827	New	+$171K	0.01%	1902

Other funds holding PDSB

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Virtu Financial's PDSB Position: Q1 2026 in Review

Virtu Financial sold out of PDS Biotechnology (PDSB) in Q1 2026, closing a stake of 32,099 shares — an estimated $25K sold.

Virtu Financial first reported a position in PDSB in Q3 2017 and held it in 10 quarters. The position peaked at $264K in Q3 2021. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

Virtu Financial reported no remaining PDS Biotechnology position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 32,099 PDS Biotechnology shares in Q1 2026, an estimated $25K.
Virtu Financial first reported a position in PDS Biotechnology in Q3 2017 and held it in 10 quarters.
Virtu Financial's PDS Biotechnology position peaked at $264K in Q3 2021.
41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.